Search research articles
Contact Us
Filters
Showing results (61-70 of 74) with videos related to
Page
of 8
Sort By:
Journal of Clinical Pathology
|
March 12, 2026
Acute myeloid leukaemia (AML) harbouring <i>KMT2A</i>-PTD: should it be considered as a myelodysplasia-related abnormality?
Narasimhapriyan Kannan, Aarti Achrekar, Vishram Terse, et al.
Hemasphere
|
April 3, 2024
Circulating tumor plasma cells and peripheral blood measurable residual disease assessment in multiple myeloma patients not planned for upfront transplant
Prashant R Tembhare, Harshini Sriram, Twinkle Khanka, et al.
Nature Cancer
|
April 5, 2022
Outcomes of COVID-19 and risk factors in patients with cancer
Manju Sengar, Girish Chinnaswamy, Priya Ranganathan, et al.
Blood Cancer Journal
|
March 15, 2025
Outcomes and prognostic factors in patients with Burkitt lymphoma/leukemia in adolescents and adults: an experience from hematology cancer consortium
Akhil Rajendra, Manju Sengar, Anu Korula, et al.
JCO Global Oncology
|
February 20, 2026
Validation and Refinement of the European LeukemiaNet 2022 Genetic Risk Stratification of AML
Gojiri Mawalankar, Aarti Achrekar, Seema Biswas, et al.
Blood
|
December 5, 2025
Early time to relapse as a survival prognosticator in mature T-cell/NK-cell lymphomas: results from the PETAL Consortium
Mark N Sorial, Luis Malpica, Carlos Sergio Chiattone, et al.
British Journal of Haematology
|
September 16, 2024
Impact of the COVID-19 pandemic on treatment of patients with acute myeloid leukaemia in India
Chepsy Philip, Sushil Selvarajan, Lingaraj Nayak, et al.
The Lancet. Haematology
|
March 16, 2025
Talicabtagene autoleucel for relapsed or refractory B-cell malignancies: results from an open-label, multicentre, phase 1/2 study
Hasmukh Jain, Atharva Karulkar, Devanshi Kalra, et al.
Cancer Medicine
|
October 31, 2020
COVID-19 in cancer patients on active systemic therapy - Outcomes from LMIC scenario with an emphasis on need for active treatment
Anant Ramaswamy, Lingaraj Nayak, Nirmalya Roy Moulik, et al.
Annals of Hematology
|
July 8, 2024
Treatment challenges and outcomes of older patients with acute myeloid leukemia from India
Suvir Singh, Sharon Lionel, Hasmukh Jain, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 74) with videos related to
Sort By:
Page
of 8
Journal of Clinical Pathology
|
March 12, 2026
Acute myeloid leukaemia (AML) harbouring <i>KMT2A</i>-PTD: should it be considered as a myelodysplasia-related abnormality?
Narasimhapriyan Kannan, Aarti Achrekar, Vishram Terse, et al.
Hemasphere
|
April 3, 2024
Circulating tumor plasma cells and peripheral blood measurable residual disease assessment in multiple myeloma patients not planned for upfront transplant
Prashant R Tembhare, Harshini Sriram, Twinkle Khanka, et al.
Nature Cancer
|
April 5, 2022
Outcomes of COVID-19 and risk factors in patients with cancer
Manju Sengar, Girish Chinnaswamy, Priya Ranganathan, et al.
Blood Cancer Journal
|
March 15, 2025
Outcomes and prognostic factors in patients with Burkitt lymphoma/leukemia in adolescents and adults: an experience from hematology cancer consortium
Akhil Rajendra, Manju Sengar, Anu Korula, et al.
JCO Global Oncology
|
February 20, 2026
Validation and Refinement of the European LeukemiaNet 2022 Genetic Risk Stratification of AML
Gojiri Mawalankar, Aarti Achrekar, Seema Biswas, et al.
Blood
|
December 5, 2025
Early time to relapse as a survival prognosticator in mature T-cell/NK-cell lymphomas: results from the PETAL Consortium
Mark N Sorial, Luis Malpica, Carlos Sergio Chiattone, et al.
British Journal of Haematology
|
September 16, 2024
Impact of the COVID-19 pandemic on treatment of patients with acute myeloid leukaemia in India
Chepsy Philip, Sushil Selvarajan, Lingaraj Nayak, et al.
The Lancet. Haematology
|
March 16, 2025
Talicabtagene autoleucel for relapsed or refractory B-cell malignancies: results from an open-label, multicentre, phase 1/2 study
Hasmukh Jain, Atharva Karulkar, Devanshi Kalra, et al.
Cancer Medicine
|
October 31, 2020
COVID-19 in cancer patients on active systemic therapy - Outcomes from LMIC scenario with an emphasis on need for active treatment
Anant Ramaswamy, Lingaraj Nayak, Nirmalya Roy Moulik, et al.
Annals of Hematology
|
July 8, 2024
Treatment challenges and outcomes of older patients with acute myeloid leukemia from India
Suvir Singh, Sharon Lionel, Hasmukh Jain, et al.
Page
of 8